10% Body weight (gain) change as criterion for the maximum tolerated dose: A critical analysis.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
10% Body weight (gain) change as criterion for the maximum tolerated dose: A critical analysis.Published in
Regulatory toxicology and pharmacology 2022;134:105235PMID
35917983ae974a485f413a2113503eed53cd6c53
10.1016/j.yrtph.2022.105235
Scopus Count
Collections
Related articles
- Regulatory Forum Commentary* Counterpoint: Dose Selection for rasH2 Mouse Carcinogenicity Studies.
- Authors: Nambiar PR, Morton D
- Issue date: 2015 Jul
- Pulmonary carcinogenicity of inhaled particles and the maximum tolerated dose.
- Authors: Oberdörster G
- Issue date: 1997 Sep
- Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
- Authors: Gaylor DW
- Issue date: 2005 Mar
- Establishing maximum tolerated doses for a 2-year combined chronic/carcinogenicity rat study based on toxicokinetic and toxicity gender differences.
- Authors: Liu Z, Wasniewski A, Lamperti S, Mainolfi K, Chandrasekaran A
- Issue date: 2017 Nov
- Regulatory Forum Opinion Piece*: Retrospective Evaluation of Doses in the 26-week Tg.rasH2 Mice Carcinogenicity Studies: Recommendation to Eliminate High Doses at Maximum Tolerated Dose (MTD) in Future Studies.
- Authors: Paranjpe MG, Denton MD, Vidmar TJ, Elbekai RH
- Issue date: 2015 Jul